Pedro Cuatrecasas

Pedro Cuatrecasas ( born September 27, 1936 in Madrid) is an American physician and pharmacologist.

Cuatrecasas studied medicine at the University of Washington in St. Louis, where in 1958 he took his bachelor's degree in 1962 and his doctorate ( MD, magna cum laude). After that, he was from 1962 to 1964 resident training ( internship, residency ) at Johns Hopkins University Hospital, and then conducted research at the National Institutes of Health ( Institute for Arthritis and Metabolic Diseases ), from 1967 as a Medical Officer, while concurrently at George Washington University Lecturer was in biochemistry. From 1970 he was an associate professor and in 1972 professor at the Johns Hopkins University Medical School. 1975 to 1986 he was director of research at Burroughs Wellcome in their research laboratories in North Carolina ( Vice President for Research ) and simultaneously an Adjunct Professor at Duke University and the University of North Carolina. From 1986, he was Senior Vice President of Research at Glaxo and 1988/89 Director of Glaxo International Research. From 1989 to 1997 he was president of the Pharmaceutical Research at Parke -Davis in Ann Arbor from 1989 to 1997 and Vice President of Warner - Lambert. From 1990 he was also an Adjunct Professor at the University of Michigan and from 1997 at the University of California, San Diego.

He is known for the invention and development of affinity chromatography. During his time in the pharmaceutical industry, he was involved in the development and launch of more than 40 drugs, including acyclovir and AZT.

In 1987 he was awarded the Wolf Prize in Medicine with Meir Wilchek. In 1972 he received the John J. Abel Award in Pharmacology.